RecruitingNot ApplicableNCT06687122

Egg Intake, Metabolic Outcomes and Choline Levels

Additional Daily Intake of Eggs for Improving Metabolic Outcomes and Choline Levels in Individuals With Obesity: Phase I Study


Sponsor

University of Guelph

Enrollment

20 participants

Start Date

Jan 24, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research is to determine the effect of additional daily egg intake on metabolic phenotypes and metabolism in the context of obesity.


Eligibility

Min Age: 30 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 3 whole eggs for people with obesity and obesity-related medical conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENT3 whole eggs

Participants will be free-living and will not be supplied with any other food except for the eggs during the intervention period with no restrictions of energy intake.


Locations(1)

Research Center of the Institut universitaire de cardiologie et de pneumologie de Québec - ULaval

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06687122


Related Trials